BioWorld

July 20, 2010

View Archived Issues

More Complex Disease, but a Shorter 'Translatability' Road

Read More

Design Controls May Be en Route for Lab-Developed Tests

Read More

Much-Anticipated 'Btripla' Data all the Talk at 2010 IAS Meeting

Read More

Other News To Note

Read More

Stock Movers

Read More

Clinic Roundup

Read More

Financings Roundup

Read More

Ramius Seeks Hostile Buyout of Cypress Bioscience at $4/Share

Activist shareholder Ramius Value and Opportunity Advisors LLC said that it is seeking to take over Cypress Bioscience Inc., offering to buy the rest of the company shares that it does not already own for $4 per share. (BioWorld Today) Read More

Is Venture Riding the Summer Roller Coaster?

Read More